INDIAN COMPANY NEWS BITES
STOCK REPORT
Sanofi India Limited (NSE:SANOFI), India's 13th largest pharmaceuticals company by market capitalisation, extended its gains Tuesday, rising an additional Rs66.55 (or 2.6%) to close at Rs2,589.35. The shares have jumped Rs180.85 (or 7.5%) over the past four trading days. Compared with the BSE Sensex Index, which fell 271.4 points (or 1.4%) on the day, this was a relative price change of 4.0%.
Bullish Signals
Uptrend
- The stock rose 2.6%, for a 4-day rise of 7.5%, on high volatility today and expanding price range.
- The stock lifted on average volume, rising for a fourth consecutive day.
- The stock hit a year-high.
- The stock continues its significant uptrend.
- The stock's relative price strength percentile is rising at 81 for 6 months, 90 for 3 months and 95 for 1 month.
- Rises to Falls: in the past month the number of rises outnumbered falls 15:6 or 2.5:1.
- The Moving Average Convergence Divergence (MACD) indicator of 12-day Exponential Moving Average (EMA) of 2,441.71 minus the 26-day EMA of 2,388.74 is positive 52.97 suggesting a bullish signal. Both EMA prices are rising, another bullish signal.
- The present value of Rs1,000 (PV1000) invested one year ago is Rs1,219, including a capital gain of Rs202 and dividend reinvested of Rs18.
PV1000 | 1-week | 1-month | 1-year |
SANOFI.NSE | 1,070 | 1,176 | 1,219 |
BSE Sensex Index | 972 | 969 | 1,122 |
Fundamental measures by comparison with the sector average [in brackets] indicate Undervaluation:
- Price/Earnings of 31.2 [41.7]. We estimate the shares are trading at a current year P/E of 27.2 and a forward year P/E of 23.7.
- Return on Equity 17.1% [9.7%].
- Return on Assets 12.7% [4.8%].
- Return on Capital Employed 25.3% [12.6%].
- Dividend yield of 1.3% [0.8%].
Other Bullish Signals:
- Total Liabilities/EBITDA of 1.2 is comfortably below 5, this compares favourably with the Joseph Piotroski benchmark of 5.
Description | Value | Rank In Market |
Price/MAP50 | 1.11 | In Top 4% |
MCap | US$1.1 billion | In Top 7% |
Price/MAP200 | 1.15 | In Top 9% |
Return on Assets [ROA] % | 12.7 | In Top Quartile |
Price Change % | 2.6 | In Top Quartile |
Return on Capital Employed [ROCE] % | 25.3 | In Top Quartile |
Net Profit Margin % | 13.7 | In Top Quartile |
Relative Strength (6M) | 81 | In Top Quartile |
EBITDA Margin % | 22.6 | In Top Quartile |
Return on Equity [ROE] % | 17.1 | In Top Quartile |
Note
Beta: the Beta of this stock is 0.5. A Beta lower than 1 suggests this is a low risk, low return stock with volatility less than that of the market.
Fundamental measures by comparison with the sector average [in brackets] indicate Overvaluation:
- Price/Sales of 4.3 [3.0].
- Price to Book of 5.3 [4.6].
Bearish Signals:
- Tobin's Q Ratio, defined as MCap divided by Total Assets, is 4. Compared with the rest of the market the stock is overvalued and ranks in the bottom 5% of stocks by value of Q Ratio.
AGGREGATE VOLUMES, PRICES AND TURNOVER PERIOD [Volume Index or VI in brackets; 1 is average]
NSE:SANOFI.NSE 4,892 [VI of 1.0] volume 73.808% of aggregate. Day trader volume: 54.8% for the d
